At the archive date, DEXCOM INC was expected to release its Q3 2026 10-Q filing on October 28, 2026. Last quarter: DexCom delivered strong financial results in Q2 FY2026, driven by a 13.1% YoY revenue increase to $1.31B and a 49.7% boost in operating income, backed by expanding gross margins and robust customer adoption.
EPS Estimate
$0.68
Revenue Estimate
$1.36B
Analyst consensus captured from Finnhub and Financial Modeling Prep. This archived preview is no longer updated with later results; see the DXCM page for retained reports.
Drawn from management commentary in the Q2 2026 10-Q:
Total revenue grew 13.1% YoY to $1.31B in Q2 FY2026, supported by U.S. revenue of $933.4M and International revenue of $375.0M. Growth was primarily driven by higher sales volumes of disposable sensors across a expanding customer base and favorable payor mix per customer.
Gross profit increased 20.5% YoY to $830.0M, with gross margin widening to 63.4% from 59.5% in Q2 FY2025. Margins expanded due to G7 15 Day rollouts, improved manufacturing efficiencies, and fixed-cost absorption, despite charges related to the planned discontinuation of G6 manufacturing.
Operating income rose to $318.3M (up 49.7% YoY) as operating expenses grew only 7.5% YoY to $511.7M. SG&A increased 9.4% to $358.7M due to higher advertising and marketing investments, while R&D expenses remained flat at $153.0M due to project timing.
Revenue
$1.31B
+13.08% YoY
EPS (Diluted)
$0.64
+42.22% YoY
Gross Margin
63.4%
+3.9 pts YoY
Operating Income
$318.3M
+49.72% YoY
Add DXCM to your watchlist to keep its archived reports easy to find. New filing alerts are no longer sent.